Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Report

Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 21, 2022
  • PAGES：184
  • REPORT CODE：GMM1479851
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astellas Pharmaceuticals

    • Pfizer

    • Salix Pharmaceuticals Ltd

    • Actavis

    • AstraZenenca

    • GlaxoSmithKline

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Preface

    • Eluxadoline

    • Alosetron

    • Rifaximin

    • Loperamide

    • Diphenoxylate + Atropine

    • Dicyclomine and Hyoscyamine

    Application:

    • Hospitals

    • Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Overview

      • 1.1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Scope and Market Segments

      • 1.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Characteristics

      • 1.1.3 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Preface

      • 1.2.2 Eluxadoline

      • 1.2.3 Alosetron

      • 1.2.4 Rifaximin

      • 1.2.5 Loperamide

      • 1.2.6 Diphenoxylate + Atropine

      • 1.2.7 Dicyclomine and Hyoscyamine

    • 1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry PEST Analysis

    • 2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry

    Chapter 3 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Manufacturer

    • 3.1 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Top 3 Players

    Chapter 4 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type (2017-2028)

    • 4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend, by Type

    • 4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis

    • 7.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type

    • 7.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Application

    • 7.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis

    • 8.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type

    • 8.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Application

    • 8.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis

    • 9.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type

    • 9.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Application

    • 9.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Company Profiles

      • 11.1 Astellas Pharmaceuticals

        • 11.1.1 Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Profiles, Application and Specification

        • 11.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Pfizer

        • 11.2.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Profiles, Application and Specification

        • 11.2.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Salix Pharmaceuticals Ltd

        • 11.3.1 Salix Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Profiles, Application and Specification

        • 11.3.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Actavis

        • 11.4.1 Actavis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Profiles, Application and Specification

        • 11.4.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 AstraZenenca

        • 11.5.1 AstraZenenca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Profiles, Application and Specification

        • 11.5.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GlaxoSmithKline

        • 11.6.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Profiles, Application and Specification

        • 11.6.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Preface (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Eluxadoline (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Alosetron (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Rifaximin (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Loperamide (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Diphenoxylate + Atropine (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Dicyclomine and Hyoscyamine (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share, by Manufacturer in 2022

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trend, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trend, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value Share, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Type (2017-2028)

    • Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Application (2017-2028)

    • Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharmaceuticals Product Profiles, Application and Specification

    • Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Salix Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Salix Pharmaceuticals Ltd Product Profiles, Application and Specification

    • Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Actavis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Actavis Product Profiles, Application and Specification

    • Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZenenca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZenenca Product Profiles, Application and Specification

    • Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US